FDA is Taking Steps to Ensure Safe COVID-19 Vaccines for Children

September 10, 2021 by Reece Nations
FDA is Taking Steps to Ensure Safe COVID-19 Vaccines for Children
Dr. Peter Marks, director of the Center for Biologics Evaluation and Research in the Food and Drug Administration, provides an update on efforts to combat COVID-19 on Capitol Hill in Washington. (Jim Lo Scalzo/Pool via AP)

WASHINGTON — With the public school year already underway around the country, the Food and Drug Administration is not taking chances when it comes to making COVID-19 vaccinations available to children younger than 12 years old.

Acting FDA Commissioner Janet Woodcock and the FDA director of the Center for Biologics Research and Evaluation, Peter Marks, released a joint statement on Friday providing clarity on the administration’s initiative to safely make COVID-19 immunizations available to young children and adolescents.

“Many of our team at the FDA are parents and grandparents themselves, and our team shares the same concerns as many in our country about protecting our loved ones from COVID-19,” Woodcock and Marks said in a written statement. “We are therefore also eager to see COVID-19 vaccines available for young children. We also know that we all share the interest in making sure this process is done with safety at top of mind.”

The FDA officials continued, “As regulators, we recognize we have an important task ahead of us that will require us to act expeditiously while undertaking an extremely meticulous and thoughtful review once we receive requests to authorize a COVID-19 vaccine for emergency use or submissions for approval of a COVID-19 vaccine for this population.”

In their release, the FDA officials announced that clinical trials with child participants are currently underway and the process will entail a follow-up period of around two months at least to “allow for proper safety monitoring following the administration” of the doses. Following a complete analysis of the data by vaccine manufacturers, the FDA will work closely with the producers to ensure the immunizations meet regulatory standards.

Following a robust examination of the clinical trials, the manufacturers can request an emergency use authorization or submit a biologics license application for approval with the FDA. After the approval requests are received, the FDA will complete independent evaluations of the data to determine the benefits and risks of the vaccine before ratifying the approvals “in a matter of weeks rather than months.”

“It’s important that the public recognize that, because young children are still growing and developing, it’s critical that thorough and robust clinical trials of adequate size are completed to evaluate the safety and the immune response to a COVID-19 vaccine in this population,” Woodcock and Marks said in a written statement. “Children are not small adults – and issues that may be addressed in pediatric vaccine trials can include whether there is a need for different doses or different strength formulations of vaccines already used for adults.”

The FDA’s ability to review the applications in a timely manner depends in part on the readiness and quality of the manufacturers’ submissions, the agency’s officials said. When a vaccine authorization for younger populations has been approved, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet to discuss further clinical recommendations.

Different dosing regimens were approved for individuals aged 12 years and older than the ones being studied for younger individuals, and FDA officials will conduct a “thorough evaluation” to ensure the vaccines do not cause unexpected safety issues separate from those already observed in adolescents and adults.

“Until we authorize or approve a vaccine for this younger population, it’s especially important that parents and others who interact closely with children under 12 years of age get vaccinated, wear masks, and follow other recommended precautions so that we can protect those who cannot yet protect themselves through vaccination,” Woodcock and Marks concluded in their release. 

A+
a-
  • COVID-19
  • FDA
  • Janet Woodcock
  • Peter Marks
  • vaccines for children
  • In The News

    Health

    Voting

    Health

    A US Veteran Died at a Nursing Home, Abandoned. Hundreds of Strangers Came to Say Goodbye

    AUGUSTA, Maine (AP) — Former U.S. Marine Gerry Brooks died alone at a nursing home in Maine, abandoned and all... Read More

    AUGUSTA, Maine (AP) — Former U.S. Marine Gerry Brooks died alone at a nursing home in Maine, abandoned and all but forgotten. Then the funeral home posted a notice asking if anyone would serve as a pallbearer or simply attend his burial. Within minutes, it was... Read More

    Majority of Americans Favor Forgiving Medical Debt, AP-NORC Poll Finds

    NEW YORK (AP) — Janille Williams wants to buy a house someday — but first, he has to pay down... Read More

    NEW YORK (AP) — Janille Williams wants to buy a house someday — but first, he has to pay down tens of thousands of dollars in medical debt. “I was hospitalized for a blood infection for three months more than ten years ago, and the bill... Read More

    Oversight Hearing on Illegal E-Cigarettes Highlights Dire Need for Reform of the FDA

    The Senate deserves credit for holding a recent hearing that underscored the failure of the U.S. Food and Drug Administration’s Center for... Read More

    The Senate deserves credit for holding a recent hearing that underscored the failure of the U.S. Food and Drug Administration’s Center for Tobacco Products to provide clear and fair regulatory pathways for smoke-free tobacco products that provide Americans with less harmful alternatives to combustible cigarettes. This hearing follows... Read More

    June 17, 2024
    by Anna Claire Miller
    Biden Campaign Redoubling Effort to Keep Abortion Rights Front of Mind for Voters

    WASHINGTON — With the second anniversary of the U.S. Supreme Court decision overturning Roe v. Wade fast approaching, the Biden-Harris... Read More

    WASHINGTON — With the second anniversary of the U.S. Supreme Court decision overturning Roe v. Wade fast approaching, the Biden-Harris campaign is organizing volunteers to share what they’ve experienced since that ruling went into effect. Decided on June 24, 2022, Dobbs v. Jackson Women's Health Organization... Read More

    Drug Shortages Keep on Growing. Older, Injectable Medicines Among the Most Vulnerable

    Erin Fox has tracked drug shortages for more than 20 years, and she sees no easy solutions for what has... Read More

    Erin Fox has tracked drug shortages for more than 20 years, and she sees no easy solutions for what has become a record run. Total active shortages hit an all-time high of 323 in this year’s first quarter, according to the University of Utah Drug Information... Read More

    Surgeon General Asks Congress to Require Warning Labels for Social Media, Like Those on Cigarettes

    The U.S. surgeon general has called on Congress to require warning labels on social media platforms similar to those now mandatory... Read More

    The U.S. surgeon general has called on Congress to require warning labels on social media platforms similar to those now mandatory on cigarette boxes. In a Monday opinion piece in the The New York Times, Dr. Vivek Murthy said that social media is a contributing factor in... Read More

    News From The Well
    scroll top